Genetic Technologies Ltd (GENE) Stock Income Statement
NASDAQ:GENE - Nasdaq - US37185R4065 - ADR - Currency: USD
| 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.66M | 8.69M | 6.79M | 120.55K | 9.86K | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | 3.76M | 4.34M | 3.01M | 170.46K | 101.43K | |||
| Gross Profit | 3.90M | 4.35M | 3.78M | -49.91K | -91.57K | |||
| Operating Expenses | 14.52M | 14.55M | 11.35M | 7.64M | 6.44M | |||
| Research and Development | 752.75K | 1.28M | 705.51K | 1.17M | 865.63K | |||
| Selling, General, and Administrative Expenses | 11.70M | 10.52M | 12.46M | 5.80M | 4.38M | |||
| Operating Income | -10.61M | -10.19M | -7.57M | -7.69M | -6.54M | |||
| Interest Income/Expense | -91.39K | 365.68K | 380.92K | 103.95K | -49.55K | |||
| Other Income/Expense | 20.76K | 45.72K | 25.96K | 216.27K | N/A | |||
| Non Recurring Items | -1.33M | -2.13M | 0.00 | 287.88K | 253.14K | |||
| Income Before Taxes | -12.02M | -11.91M | -7.16M | -7.08M | -6.29M | |||
| Income Tax | 0.00 | -158.33K | -32.13K | 0.00 | 0.00 | |||
| Net Income | -12.02M | -11.75M | -7.13M | -7.08M | -6.29M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.02 | -5.13 | -3.42 | -3.66 | -0.07 | |||
| Statistics | ||||||||
| Gross Profit Margin | 50.94% | 50.09% | 55.65% | -41.40% | -928.70% | |||
| Profit Margin | -156.78% | -135.28% | -104.95% | -5871.11% | -63841.58% | |||
| Operating Profit Margin | -138.49% | -117.37% | -111.41% | -6375.55% | -66281.54% | |||
All data in AUD